9 Meters Biopharma, Inc. (NMTR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7050+0.0450 (+2.71%)
As of 12:11PM EST. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 1.6600 |
| Open | 1.7400 |
| Bid | 1.7300 x 4000 |
| Ask | 1.7400 x 2900 |
| Day's Range | 1.7000 - 1.7800 |
| 52 Week Range | 0.3700 - 2.2600 |
| Volume | 2,278,441 |
| Avg. Volume | 11,293,796 |
| Market Cap | 346.8M |
| Beta (5Y Monthly) | -0.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 12, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.25 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- ACCESSWIRE
9 Meters Biopharma, Inc. Appoints Michael Rice to Board of Directors
RALEIGH, NC / ACCESSWIRE / March 1, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the Company has appointed Michael Rice to its board of directors.
- ACCESSWIRE
9 Meters Biopharma, Inc. to Present at the 23rd Annual BIO CEO & Investor Conference
RALEIGH, NC / ACCESSWIRE / February 10, 2021 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced that its Chief Executive Officer, John Temperato, will present a corporate overview and participate in one-on-one investor meetings at the BIO CEO & Investor Conference.
- Zacks
9 Meters Biopharma (NMTR) is Overbought: Is A Drop Coming?
9 Meters Biopharma (NMTR) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
© 2021 Verizon Media. All rights reserved.
